Brief: Eagle Pharmaceuticals Reports Second Quarter 2021 Results
09/08/2021 11:51
Aug 9 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS REPORTS SECOND QUARTER 2021 RESULTS
* Q2 EARNINGS PER SHARE $0.27
* Q2 REVENUE $48.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$45.9
MILLION
* Q2 EARNINGS PER SHARE ESTIMATE $0.80 -- REFINITIV IBES
DATA
* Q2 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.93
Source text for Eikon: ID:nBw8GWN4xa
Further company coverage: EGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq